In the six-month period to June 2020, ORPH focused on integration and restructuring following its acquisition of lab services and challenge studies specialist hVIVO in January. The company is currently positioned to deliver and maximise the potential its world-leading clinical research organisation
30 Sep 2020
Open Orphan: Firm foundations for growth laid in H1
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Open Orphan: Firm foundations for growth laid in H1
hVIVO plc (HVO:LON) | 29.0 0 0.0% | Mkt Cap: 197.3m
- Published:
30 Sep 2020 -
Author:
Emma Ulker -
Pages:
4
In the six-month period to June 2020, ORPH focused on integration and restructuring following its acquisition of lab services and challenge studies specialist hVIVO in January. The company is currently positioned to deliver and maximise the potential its world-leading clinical research organisation